| 摘要 |
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator. The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator. The invention relates to a molding mass provided with impact resistance, in particular an impact-resistant PMMA having improved optical properties at elevated temperatures, molded items that can be obtained therefrom, and the use of the molding mass and the molded items. |
